News & Events

April New Hires & Promotions

April 30, 2019

CTI welcomes all the new employees who have recently joined the team, and congratulates the employees who have recently received a promotion! Erin Brown joins as Regulatory Affairs Study Start-Up Specialist I Sam Bruno joins as Research Associate Ashley Butler promoted to Research Scientist II, Regulatory & Scientific Affairs ...

Read More

CTI CEO to Speak on European Regen Med Clinical Trials at Meeting on the Mediterranean

April 18, 2019

Timothy Schroeder, CEO of CTI Clinical Trial and Consulting Services (CTI), a global, privately held, full-service contract research organization, will chair a panel at the Alliance for Regenerative Medicine (ARM) Cell and Gene Meeting on the Mediterranean in Barcelona, Spain. The panel is titled, "European Clinical Trials in a ...

Read More

CTI Announces Promotions in the Regulatory and Scientific Affairs and Medical Affairs Departments

April 11, 2019

FOR IMMEDIATE RELEASE [Covington, KY ~ April 11, 2019] CTI Clinical Trial and Consulting Services (CTI), a multi-national, privately held, full-service contract research organization is pleased to announce the promotions of Dr. John Adams and Dr. Bob Gaston ...

Read More

CTI Honored at 2019 Innovation & Technology Awards

April 5, 2019

CTI Clinical Trial and Consulting Services (CTI), a multi-national, privately held, full-service contract research organization was honored by Cincinnati Business Courier at last night's 2019 Innovation & Technology awards. CTI was named a finalist in the Outstanding Bioscience Innovation award category. This award recognizes a company that has achieved a ...

Read More

CTI Announces US Expansion on East and West Coasts

April 3, 2019

Read More

Subscribe to our mailing list

* indicates required
What best describes your relationship with CTI?
Areas of Interest (check all that apply)

Please select all the ways you would like to hear from CTI Clinical Trial & Consulting:

You can unsubscribe at any time by clicking the link in the footer of our emails. For information about our privacy practices, please visit our website.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices here.

View Privacy Policy